These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6872202)

  • 21. Occlusive disease associated with popliteal aneurysms: impact on long term graft patency.
    Borowicz MR; Robison JG; Elliott BM; Brothers TE; Robinson CK
    J Cardiovasc Surg (Torino); 1998 Apr; 39(2):137-40. PubMed ID: 9638994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing patency of the autogenous vein-femoropopliteal bypass graft: an analysis of 74 cases.
    Koontz TJ; Stansel HC
    Surgery; 1972 May; 71(5):753-9. PubMed ID: 5026965
    [No Abstract]   [Full Text] [Related]  

  • 23. Distal profunda femoris to popliteal artery bypass for patients with a short length of long saphenous vein.
    Buxton B; Reeves L; Roberts AK
    Surgery; 1978 Mar; 83(3):245-7. PubMed ID: 628887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The great saphenous vein used in situ after vein valve extirpation. Long term results.
    Rostad H; Hall KV; Dundas P
    J Cardiovasc Surg (Torino); 1979; 20(6):545-52. PubMed ID: 511920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Above-knee polytetrafluoroethylene femoropopliteal bypass graft: Is it a reasonable alternative to the below-knee reversed autogenous vein graft?
    O'Donnell TF; Farber SP; Richmand DM; Deterling RA; Callow AD
    Surgery; 1983 Jul; 94(1):26-31. PubMed ID: 6857508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of autogenous reversed saphenous vein femoropopliteal grafting: pathophysiology and prevention.
    LiCalzi LK; Stansel HC
    Surgery; 1982 Mar; 91(3):352-8. PubMed ID: 7058518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?
    Sterpetti AV; Schultz RD; Feldhaus RJ; Peetz DJ
    J Vasc Surg; 1985 Nov; 2(6):907-12. PubMed ID: 3877178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Femoropopliteal bypass with a compliant, composite polyurethane/Dacron graft: short-term results of a multicentre trial.
    Dereume JP; van Romphey A; Vincent G; Engelmann E
    Cardiovasc Surg; 1993 Oct; 1(5):499-503. PubMed ID: 8076085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and anatomic considerations for surgery in femoropopliteal disease and the results of surgery.
    Taylor LM; Porter JM
    Circulation; 1991 Feb; 83(2 Suppl):I63-9. PubMed ID: 1991402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Femoropopliteal vein grafts for claudication. Analysis of 100 consecutive cases.
    Alinaji ; Barker CF; Berkowitz HD; Chu J; Roberts B
    Ann Surg; 1978 Jul; 188(1):79-82. PubMed ID: 666381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polytetrafluoroethylene vein composite grafts across the knee.
    Scribner RG; Beare JP; Harris EJ; Sydorak GR; Tawes RL; Brown WH
    Surg Gynecol Obstet; 1983 Sep; 157(3):237-41. PubMed ID: 6612572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autogenous vein grafts for femoropopliteal arterial repair.
    Dale WA
    Surg Gynecol Obstet; 1966 Dec; 123(6):1282-8. PubMed ID: 5953961
    [No Abstract]   [Full Text] [Related]  

  • 33. The closure index: prediction of long-term patency of femoropopliteal vein grafts.
    LiCalzi LK; Stansel HC
    Surgery; 1982 Apr; 91(4):413-8. PubMed ID: 7064096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distal runoff and the development of degenerative changes in autologous reversed saphenous vein femoropopliteal bypass.
    Sterpetti AV; Sapienza P; Cavallaro A
    Ann Vasc Surg; 2011 Aug; 25(6):766-9. PubMed ID: 21514108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ femoropopliteal and distal vein bypass for limb salvage--experience of 50 cases.
    Denton MJ; Hill D; Fairgrieve J
    Br J Surg; 1983 Jun; 70(6):358-61. PubMed ID: 6860911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Femoropopliteal graft failures. Clinical consequences and success of secondary reconstructions.
    Brewster DC; LaSalle AJ; Robison JG; Strayhorn EC; Darling RC
    Arch Surg; 1983 Sep; 118(9):1043-7. PubMed ID: 6615212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors for thrombosis of PTFE femoropopliteal bypass grafts and the management of this complication.
    Tilanus HW; Obertop H; Van Urk H; Terpstra OT; van Seyen AJ
    Neth J Surg; 1988 Apr; 40(2):37-40. PubMed ID: 3374820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early experience utilizing the in situ saphenous vein technique in 54 patients.
    Strayhorn EC; Wohlgemuth S; Deuel M; Glickman MH; Hurwitz RL
    J Cardiovasc Surg (Torino); 1988; 29(2):161-5. PubMed ID: 3360836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts.
    Jackson MR; Belott TP; Dickason T; Kaiser WJ; Modrall JG; Valentine RJ; Clagett GP
    J Vasc Surg; 2000 Sep; 32(3):498-504; 504-5. PubMed ID: 10957656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.